Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Partha S Biswas - , Hospital for Special Surgery (HSS) (Autor:in)
  • Sanjay Gupta - , Hospital for Special Surgery (HSS) (Autor:in)
  • Roslynn A Stirzaker - , Hospital for Special Surgery (HSS) (Autor:in)
  • Varsha Kumar - , Hospital for Special Surgery (HSS) (Autor:in)
  • Rolf Jessberger - , Institut für Physiologische Chemie (Autor:in)
  • Theresa T Lu - , Hospital for Special Surgery (HSS), Weill Cornell Medical College, Cornell University (Autor:in)
  • Govind Bhagat - , New York Presbyterian Hospital (Autor:in)
  • Alessandra B Pernis - , Hospital for Special Surgery (HSS), Weill Cornell Medical College, Cornell University (Autor:in)

Abstract

Effective humoral responses to protein antigens require the precise execution of carefully timed differentiation programs in both T and B cell compartments. Disturbances in this process underlie the pathogenesis of many autoimmune disorders, including systemic lupus erythematosus (SLE). Interferon regulatory factor 4 (IRF4) is induced upon the activation of T and B cells and serves critical functions. In CD4(+) T helper cells, IRF4 plays an essential role in the regulation of IL-21 production, whereas in B cells it controls class switch recombination and plasma cell differentiation. IRF4 function in T helper cells can be modulated by its interaction with regulatory protein DEF6, a molecule that shares a high degree of homology with only one other protein, SWAP-70. Here, we demonstrate that on a C57BL/6 background the absence of both DEF6 and SWAP-70 leads to the development of a lupus-like disease in female mice, marked by simultaneous deregulation of CD4(+) T cell IL-21 production and increased IL-21 B cell responsiveness. We furthermore show that DEF6 and SWAP-70 are differentially used at distinct stages of B cell differentiation to selectively control the ability of IRF4 to regulate IL-21 responsiveness in a stage-specific manner. Collectively, these data provide novel insights into the mechanisms that normally couple and coordinately regulate T and B cell responses to ensure tight control of productive T-B cell interactions.

Details

OriginalspracheEnglisch
Seiten (von - bis)581-596
Seitenumfang16
FachzeitschriftJournal of Experimental Medicine
Jahrgang209
Ausgabenummer3
PublikationsstatusVeröffentlicht - 12 März 2012
Peer-Review-StatusJa

Externe IDs

Scopus 84860376756
PubMed 22370718
PubMedCentral PMC3302237

Schlagworte

Schlagwörter

  • Animals, Autoantibodies/biosynthesis, Autoimmune Diseases/immunology, B-Lymphocytes/immunology, Cell Differentiation, DNA-Binding Proteins/deficiency, Female, Guanine Nucleotide Exchange Factors/deficiency, Interferon Regulatory Factors/immunology, Interleukins/biosynthesis, Lymphocyte Cooperation/immunology, Lymphoproliferative Disorders/etiology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Minor Histocompatibility Antigens, Nuclear Proteins/deficiency, Plasma Cells/immunology, T-Lymphocytes/immunology